BBIO Chart
See on advanced chart >
About
BridgeBio Pharma, Inc. was formed as a Delaware corporation on May 17, 2019. They are a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their...
Read More
- HighlightA commercial-stage biopharmaceutical company focused on genetic diseases and cancers
- ExchangeNASDAQ
- Listing Date06/27/2019
- Established Date05/17/2019
- Full-time Employees550
- Address3160 Porter Drive Suite 250 Palo Alto CA 94304
- Tel1-650-3919740
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology